SCHEMBL30980669

SCHEMBL30980669

C=CCOCCOCCOCCNC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.47
HTR1A P08908 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
CA12 O43570 4/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
IDO1 P14902 1/20 0.39
BCHE P06276 1/20 0.39
CNR2 P34972 1/20 0.39
EPHX1 P07099 1/20 0.38
EGFR P00533 1/20 0.36
ITK Q08881 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21106804 1.00 ADRB2 (0.47) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL23728637 1.00 ADRB2 (0.47) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL13114987 0.97 TDP1 (0.47) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL25657888 0.89 ADRB2 (0.44) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL8843547 0.88 TDP1 (0.53) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL22276641 0.87 TDP1 (0.56) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL22276648 0.87 TDP1 (0.56) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL12885084 0.87 TDP1 (0.56) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL27317790 0.86 TDP1 (0.55) ADRB2HTR1ATDP1MEN1KMT2A
SCHEMBL12079730 0.86 ADRB2 (0.43) ADRB2HTR1ATDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 WO disclosed